CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 53 enrolled
Drug / intervention
Neuro Zti +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02941627
NCT02941627N/ACompleted

The Neuro Zti Cochlear Implant System Efficacy and Safety in Adults

Oticon Medical·interventional·Posted Oct 21, 2016·Updated Nov 10, 2021

In Brief

A clinical study evaluating Neuro Zti and Neuro One for Hearing Loss, Sensorineural and 2 related conditions. Completed, enrolled 53 participants across 6 sites in 2 countries.

Detailed Summary

The purpose of the study is to assess the efficacy and the safety profile of the Neuro Cochlear Implant System (CIS) in adults with severe-to-profound hearing loss.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada, Denmark
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedOct 21, 2016
Enrollment StartFeb 2, 2017
Primary CompletionNov 22, 2019
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 9.7 years ago

Interventions

Neuro Ztidevice

Cochlear implant

Neuro Onedevice

Sound processor